InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Wolf Jeffrey Alan, 董事长兼首席执行官. Director active across 2 companies, notably HEAT BIOLOGICS, INC.. Cumulatively, 2 reports have been logged. History available since 13 December 2021. The latest transaction was filed on 13 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Jeffrey Alan Wolf is the Chief Executive Officer of Heat Biologics, Inc. In this role, he oversees the strategic and commercial operations of the company, which specializes in developing immunological treatments. With extensive experience in the field, he is committed to leading the company towards innovation and sustainable growth. His leadership is essential for strengthening Heat Biologics' market position.